Gene therapy for restenosis - What now, what next?

Current Gene Therapy

Volumn 4, Issue 2, 2004, Pages 153-182

  Appleby, C E ^a   Kingston, P A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Angioplasty; Neointima; Restenosis; Smooth Muscle and Gene Therapy; Stent

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; COLCHICINE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DECORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; GLYCOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOFECTIN; LIPOSOME; NAKED DNA; PLACEBO; PLASMID DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; POLYMER; PROBUCOL; PROTEIN P21; THYMIDINE KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANILAST; TRAPIDIL; UNINDEXED DRUG; VIRUS DNA;

BIOLOGICAL MODEL; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; BRACHYTHERAPY; CELL MIGRATION; CELL PROLIFERATION; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY; DOSE TIME EFFECT RELATION; DRUG TARGETING; ENDOTHELIUM INJURY; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PATHOPHYSIOLOGY; RESTENOSIS; REVIEW; TRANSGENE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

ANIMALIA;

EID: 3042513286     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523043346435     Document Type: Review

References (215)

1. Abendschein, D.R., Recchia, D., Meng, Y.Y., Oltrona, L., Wickline, S.A., Eisenberg, P.R. (1996) Inhibition of thrombin attenuates stenosis after arterial injury in minipigs. J. Am. Coll. Cardiol., 28:1849-1855.
2. Agnelli, G. (1996) Thrombin plays a pivotal role in vascular occlusion after PTCA and coronary thrombolysis. Circ. Res., 31:232-234.
3. Appelman, Y.E., Piek, J.J., Strikwerda, S., Tijssen, J.G., de Feyter, P.J., David, G.K., Serruys, P.W., Margolis, J.R., Koelemay, M.J., Montauban, van Swijndregt, E.W., Koolen, J.J. (1996) Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet, 347:79-84.
4. Asahara, T., Chen, D., Tsurumi, Y., Kearney, M., Rossow, S., Passeri, J., Symes, J.F., Isner, J.M. (1996) Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation, 94:3291-3302.
5. Ascher, E., Scheinman, M., Hingorani, A., Seth, P., Marella, V.K., Jacob, T. (2000) Effect of p53 gene therapy combined with CTLA4Ig selective immunosuppression on prolonged neointima formation reduction in a rat model. Ann. Vasc. Surg., 14:385-392.
6. Atsuchi, N., Nishida, T., Marutsuka, K., Asada, Y., Kamikubo, Y., Takeshita, A., Ueno, H. (2001) Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries. Circulation, 103:570-575.
7. Azevedo, L.C., Pedro, M.A., Souza, L.C., de Souza, H.P., Janiszewski, M., da Luz, P.L., Laurindo, F.R. (2000) Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc. Res., 47:436-445.
8. Barbee, R.W., Stapleton, D.D., Madras, D.E., Ré, R.N., Murgo, J.P., Davenport, W.D., Giardina, J., Cook, J.L. (1995) Retroviral suicide vector does not inhibit neointimal growth in a porcine coronary model of restenosis. Biochem. Biophys. Res. Comm., 207:89-98.
9. Barolet, A.W., Nili, N., Cheema, A., Robinson, R., Natarajan, M.K., O'Blenes, S., Li, J., Eskandarian, M.R., Sparkes, J., Rabinovitch, M., Strauss, B.H. (2001) Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor. Arterioscler. Thromb. Vasc. Biol., 21:1269-1274.
10. Bauters, C., Marotte, F., Hamon, M., Oliviero, P., Farhadian, F., Robert, V., Samuel, J.L., Rappaport, L. (1995) Accumulation of fetal fibronectin mRNAs after balloon denudation of rabbit arteries. Circulation, 92:904-911.
11. Bendeck, M.P., Zempo, N., Clowes, A.W., Galardy, R.E., Reidy, M.A. (1994) Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res., 75:539-545.
12. Bendeck, M.P., Regeness, S., Tom, W.D., Giachelli, C.M., Schwartz, S..M, Hart, C., Reidy, M.A. (1996a) Differential expression of α1 type VIII collagen in injured platelet-derived growth-factor BB-stimulated rat carotid arteries. Circ. Res., 79:524-31.
13. Bendeck, M.P., Irvin, C., Reidy, M.A. (1996b) Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ. Res., 78:38-43.
14. Benihoud, K., Yeh, P., Perricaudet, M. (1999) Adenovirus vectors for gene delivery. Curr. Opin. Biotech., 10:440-447.
15. Bennett, M.R. and O'Sullivan, M. (2001) Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy. Pharmacol. Ther., 91:149-166.
16. Bishop, G.G., Wiegman, P., McNamara, C., Din, S., Sanders, J., Hesselbacher, S., Feldman, M., McPherson, J.A., Humphries, J.E., Hammarskjold, M-L., Gimple, L.W., Ragosta, M., Powers, E.R., Dichek, D., Owens, G.K., Sarembock, I.J. (1999) Local adenovirus-mediated delivery of hirudin in a rabbit arterial injury model. J. Vasc. Res., 36:343-352.
17. Bittle, J.A. (1996) Advances in coronary angioplasty. N. Engl. J. Med., 335:1290-1302.
18. Brieger, D. and Topol, E. (1997) Local drug delivery systems and prevention of restenosis. Cardiovasc. Res., 35:405-413.
19. Brown, D.L., George, C.J., Steenkiste, A.R., Cowley, M.J., Leon, M.B., Cleman, M.W., Moses, J.W., King, S.B., Carrozza, J.P., Holmes, D.R., Burkhard-Meier, C., Popma, J.J., Brinker, J.A., Buchbinder, M. (1997) High-speed rotational atherectomy of human coronary stenoses: acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registry. Am. J. Cardiol., 80(10A):60K-67K
20. Bult, H. (2000) Restenosis: a challenge for pharmacology. Trends Pharmacol. Sci., 21:274-279.
21. Carmeliet, P., Moons, L., Lijnen, R., Janssens, S., Lupu, F., Collen, D., Gerard, R.D. (1997) Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation. Circulation, 96:3180-3191.
22. Casscells, W. (1992) Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation, 86:723-729.
23. Chandrasekar, B. and Tanguay, J-F. (2000) Platelets and restenosis. J. Am. Coll. Cardiol., 35:555-562.
24. Chang, M.W., Barr, E., Seltzer, J., Jiang, Y.Q., Nabel, G.J., Nabel, E.G., Parmacek, M.S., Leiden, J.M. (1995a) Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science, 267:518-22.
25. Chang, M.W., Barr, E., Lu, M.M., Barton, K., Leiden, J.M. (1995b) Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid model of balloon angioplasty. J. Clin. Invest., 96:2260-68.
26. KIP1, an inhibitor of neointimal formation in the rat carotid artery. J. Clin. Invest., 99:2334-2339.
27. Chen, D., Asahara, T., Krasinski, K., Witzenbichler, B., Yang, J., Magner, M., Kearney, M., Frazier, W.A., Isner, J.M. (1999) Antibody blockade of thrombospondin accelerates reendothelization and reduces neointima formation in balloon injured rat carotid artery. Circulation, 100:849-854.
28. Cheng, L., Mantile, G., Pauly, R., Nater, C., Felici, A., Monticone, R., Bilato, C., Gluzband, Y.A., Crow, M.T., Stetler-Stevenson, W., Capogrossi, M.C. (1998) Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation, 98:2195-2201.
29. Christen, T., Bochaton-Piallat, M.L., Neuville, P., Rensen, S., Redard, M., van Eys, G., Gabbiani, G. (1999) Cultured porcine artery smooth muscle cells. A new model with advanced differenciation. Circ. Res., 85:99-107.
30. Christen, T., Verin, V., Bochaton-Piallat, M-L., Popowski, Y., Ramaekers, F., Debruyne, P., Camenzid, E., van Eys, G., Gabbiani, G. (2001) Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation, 102:882-888.
31. Chu, Y., Heistad, D.D., Cybulsky, M.I., Davidson, B.L. (2001) Vascular cell adhesion molecule-I augments adenovirus-mediated gene transfer. Arterioscler. Thromb. Vasc. Biol., 21:238-242.
32. Claudio, P.P., Frata, L., Farina, F., Howard, C.M., Stassi, G., Numata, S-I., Pacilio, C., Davis, A., Lavitrano, M., Volpe, M., Wilson, J.M., Trimarco, B., Giordano, A., Condorelli, G. (1999) Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty. Circ. Res., 85:1032-1039.
33. Cleek, R.L., Rege, A.A., Denner, L.A., Eskin, S.G., Mikos, A.G. (1997) Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. J. Biomed. Mater. Res., 35:525-530.
34. Condorelli, G., Aycock, J.K., Frati, G., Napoli, C. (2001) Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J, 15:2162-70.
35. Costa, M.A., Sabaté, M., van der Giessen, W.J., Kay, P., Cervinka, P., Lithgart, J.M.R., Serrano, P., Coen, V.L.M.A., Levendag, P.C., Serruys, P.W. (1999) Late coronary occlusion after intracoronary brachytherapy. Circulation, 100:789-792.
36. Côté, G., Tardif, J-C., Lespérance, J., Lambert, J., Bourassa, M., Bonan, R., Gosselin, G., Joyal, M., Tanguay, J-F., Nattel, S., Gallo, R., Crépeau, J. (1999) Effects of probucol on vascular remodeling after coronary angioplasty. Circulation, 99:30-35.
37. Deguchi, J., Namba, T., Hamada, H., Nakaoka, T., Abe, J., Sato, O., Miyata, T., Makuuchi, M., Kurokawa, K., Takuwa, Y. (1999) Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther., 6:956-965.
38. De Young, M.B., Tom, C., Dichek, D.A. (2001) Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries. Circulation. 104:1972-1977.
39. Ding, H., Wang, R., Marcel, R., Fisher, D.Z. (2001) Adenovirus-mediated expression of a truncated PDGFβ receptor inhibits thrombosis and neointima formation in an avian arterial injury model. Thromb. Haemost, 86:914-922.
40. Dollery, C.M., Humphries, S.E., McClelland, A., Latchman, D.S., McEwan, J.R. (1999) Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation, 99:3199-3205.
41. Duckers, H.J., Boehm, M., True, A.L., Yet, S-W., San, H., Park, C.L., Webb, R.C., Lee, M-E., Nabel, G.J., Nabel, E.G. (2001) Heme oxygenase-1 protects against vascular constriction and proliferation. Nature Med., 7:693-698.
42. Emanueli, C., Salis, M.B., Chao, J., Chao, L., Agata, J., Lin, K-F., Muanò, A., Straino, S., Minasi, A., Capogrossi, M.C., Madeddu, P. (2000) Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice. Arterioscler. Thromb. Vasc. Biol., 20:1459-1466.
43. Eto, Y., Shimokawa, H., Hiroki, J., Morishige, K,. Kandabashi, T., Matsumoto, Y., Amano, M., Hoshijima, M., Kaibuchi, K., Takeshita, A. (2000) Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs. Am. J. Physiol. Heart Circ. Physiol., 278:H1744-1750
44. Evanko, S.P., Angello, J.C., Wight, T.N. (1999) Formation of hyaluronan-and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 19:1004-1013.
45. Feldman, L.G., Steg, P.G., Zheng, L.P., Chen, D., Kearney, M., McGarr, S.E., Barry, J.J., Dedieu, J.F., Perricaudet, M., Isner, J.M. (1995) Low efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J. Clin. Invest., 95:2662-2671.
46. Fischer, J.W., Kinsella, M.G., Clowes, M.M., Lara, S., Clowes, A.W., Wight, T.N. (2000) Local expression of bovine decorin by cell-mediated gene transfer reduces neointimal formation after balloon injury in rats. Circ. Res., 86:676-683.
47. Fischman, D.L., Leon, M.B., Baim, D.S., Schatz, R.A., Savage, M.P., Penn, I., Detre, K., Veltri, L., Ricci, D., Nobuyoshi, M., et al. (1994) A randomised comparison of coronary stent placement and PTCA in treatment of coronary artery disease. N. Engl. J. Med., 331:496-501.
48. Forough, K., Kayama, N., Hasenstab, D., Lea, H., Clowes, M., Nikkari, S.T., Clowes, A.W. (1996) Overexpression of TIMP-1 inhibits smooth muscle cell function in vitro and in vivo. Circ. Res., 79:812-820.
49. Forrester, J.S., Fishbein, M., Helfont, R., Fagan, J. (1991) A paradigm for restenosis based on cell biology: Clues for development of new preventative therapies. J. Am. Coll. Cardiol., 17:758-769.
50. French, B.A., Mazur, W., Ali, N.M., Geske, R.S., Finnigan, J.P., Rodgers, G.P., Roberts, R., Raisner, A.E. (1994) Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries and two models of coronary restenosis. Circulation, 90:2402-2413.
51. Garas, S.M., Huber, P., Scott, N.A. (2001) Overview of therapies for prevention of restenosis after coronary interventions. Pharmacol. Ther., 92:165-178.
52. George, S.J., Lloyd, C.T., Angelini, G.D., Newby, A.C., Baker, A.H. (2000) Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation, 101:296-304.
53. Giachelli, C.M., Bae, N., Almeida, M., Denhardt, D.T., Alpers, C.E., Schwartz, S.M. (1993) Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest., 92:1686-1696.
54. Guarda, E., Katwa, L.C., Campbell, S.E., Tanner, M.A., Webel, R.M., Laughlin, H., Jenkins, S., Myers, P.R. (1996) Extracellular matrix collagen synthesis and degradation following coronary balloon angioplasty. J. Mol. Cell. Cardiol., 28:699-706.
55. Guzman, R.J., Hirschowitz, E.A., Brody, S.L., Crystal, R.G., Epstein, S.E., Finkel, T. (1994) In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Nat. Acad. Sci., 91:10732-10736.
56. Hanke, H., Strohschneider, T., Oberhoff, M., Betz, E., Karsch, K.R. (1990) Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ. Res., 67:651-659.
57. Harada, M., Toki, Y., Numaguchi, Y., Osanai, H., Ito, T., Okumura, K., Hayakawa, T. (1999) Prostacyclin synthase gene transfer inhibits neointimal formation in rat balloon-injured arteries without bleeding complications. Cardiovasc. Res., 43:481-491.
58. Harrell, R., Rajanayagam, S., Doanes, M., Guzman, R., Hirschowitz, E., Crystal, R.G., Epstein, S.E., Finkel, T. (1997) Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus mediated gene transfer of cytosine deaminase. Circulation, 96:621-627.
59. Hasenstab, D., Lea, H., Clowes, A.W. (2000) Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening. Arterioscler. Thromb. Vasc. Biol., 20:853-859.
60. Hayashi, K., Nakamura, S., Morishita, R., Moriguchi, A., Aoki, M., Matsumoto, K., Nakamura, T., Kaneda, Y., Sakai, N., Ogihara, T. (2000) In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Gene Ther., 7:1664-1671.
61. Hermans, W.R., Rensing, B.J., Foley, D.P., Deckers, J.W., Rutsch, W., Emanuelsson, H., Danchin, N., Wijns, W., Chappuis, F., Serruys, P.W. (1992) Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis). J. Am. Coll Cardiol., 20:767-780
62. Hiltunen, M.O., Laitinen, M., Turunen, M.P., Jeltsch, M., Hartikainen, J., Rissanen, T.T., Laukkanen, J., Niemi, M., Kossila, M., Häkkinen, T.P., Kivelä, A., Enholm, B., Mansukoski, H., Turunen, A-M., Alitalo, K., Ylä-Herttuala, S. (2000) Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation, 102:2262-2268.
63. Hoffmann, R., Mintz, G.S., Dussaillant, G.R., Popma, J.J., Pichard, A.D., Satler, L.F., Kent, K.M., Griffin, J., Leon, M.B. (1996) Patterns and mechanisms of In-stent restenosis. A serial vascular ultrasound study. Circulation, 94:1247-1254.
64. Holmes, D.R., Savage, M., LaBlanche, J.M., Grip, L., Serruys, P.W., Fitzgerald, P., Fischman, D., Goldberg, S., Brinker, J.A., Zeiher, A.M., Shapiro, L.M., Willerson, J., Davis, B.R., Ferguson, J.J., Popma, J., King, S.B., Lincoff, A.M., Tcheng, J.E., Chan, R., Granett, J.R., Poland, M. (2002) Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation, 106:1243-1250.
65. Huehns, T.Y., Krausz, E., Mrochen, S., Schmid, M., Engelmann, M.G., Esin, S., Schrittenloher, P-K., Höfling, B., Günzburg, W.H., Nikol, S. (1999) Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter. Atherosclerosis, 144:135-150.
66. Iaccarino, G., Smithuck, L.A., Lefkowitz, R.J., Koch, W.J. (1999) Targeting Gβγ signalling in arterial vascular smooth muscle cell proliferation: a novel strategy to limit restenosis. Proc. Natl. Acad. Sci., 96:3945-50.
67. Indolfi, C., Avvedimento, E.V., Rapacciuolo, A., Esposito, G., Di Lorenzo, E., Leccia, A., Pisani, A., Chieffo, A., Coppola, A., Chiariello, M. (1997) In vivo gene transfer: prevention of neointima formation by inhibition of mitogen-activated protein kinase kinase. Basic Res. Cardiol., 92:378-384.
68. Izumi, Y., Kim, S., Namba, M., Yasumoto, H., Miyazaki, H., Hoshiga, M., Kaneda, Y., Morishita, R., Zhan, Y., Iwao, H. (2001) Gene transfer of dominant-negative mutants of extracellular signal-related kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ. Res., 88:1120-1126.
69. Janssens, S., Flaherty, D., Nong, Z., Varenne, O., van Pelt, N., Haustermans, C., Zoldhelyi, P., Gerard, R., Collen, D. (1998) Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation, 97:1274-1281.
70. Kafri, T., Morgan, D., Krahl, T., Sarvetnick, N., Sherman, L., Verma, I. (1998) Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy. Proc. Nat. Acad. Sci., 95:11377-11382.
71. Kakuta, T., Currier, J.W., Haudenschild, C.C., Ryan, T.J., Faxon, D.P. (1994) Differences in compensatory vessel enlargement not intimal formation, account for restensosis after angioplasty in hypercholesteroleamic rabbit model. Circulation, 89:2809-2815.
72. Kaneda, Y., Saeki, Y., Morishita, R. (1999) Gene therapy using HVJ-liposomes: the best of both worlds? Mol. Med. Today, 5:298-303.
73. Karim, M.A., Miller, D.D., Farrar, M.A., Eleftheriades, E., Reddy, B.H., Breland, C.M., Samarel, A.M. (1995) Histomorphometric and biochemical correlates of arterial procollagen gene expression during vascular repair after experimental angioplasty. Circulation, 91:2049-2057.
74. Kastrati, A., Schömig, A., Dirschinger, J., Mehilli, J., Dotzer, F., von Welser, N., Neumann, F-J. (2000) A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. Circulation, 102:2593-2598.
75. Kingston, P.A., Sinha, S., David, A., Castro, M.G., Lowenstein, P.R., Heagerty, A.M. (2001) Adenovirus-mediated gene transfer of a secreted transforming growth factor-β type II receptor inhibits luminal loss and constrictive remodeling post-coronary angioplasty and enhances adventitial collagen deposition. Circulation, 104:2595-2601.
76. Kirchengast, M., Münter, K. (1998) Endothelin and restenosis. Cardiovasc. Res., 39:550-555.
77. Klugherz, B. D., Jones, P. L., Cui, X., Chen, W., Meneveau, N. F., DeFelice, S., Connolly, J., Wilensky, R. L., Levy, R. J. (2000) Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat. Biotechnol., 18:1181-1184.
78. Klugherz, B.D., Song, C., DeFelice, S., Cui, X., Lu, Z., Connolly, J., Hinson, J.T., Wilensky, R.L., Levy, R.J. (2002) Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum. Gene. Ther., 13:443-454.
79. Koyama, H., and Reidy, M.A. (1998) Expression of extracellular matrix proteins accompanies lesion growth in a model of intimal reinjury. Circ. Res., 82:988-995
80. Kremer, E.J. and Perricaudet, M. (1995) Adenovirus and adeno-associated virus mediated gene transfer. Br. Med. Bull., 51:31-44.
81. Kutryk, M.J., Foley, D.P., van den Brand, M., Hamburger, J.N., van der Giessen, W.J., deFeyter, P.J., Bruining, N., Sabate, M., Serruys, P.W. ITALICS Trial. Local intracoronary administration of antisnse oligonucleotide against c-myc for the prevention of in-stent restenosis. Results of randomised investigation by the thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial. J. Am. Coll. Cardiol., 39: 281-287.
82. Labinaz, M., Pels, K., Hoffert, C., Aggarwal, S., O'Brien, E.R. (1999) Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries. Cardiovasc. Res., 41:266-266.
83. Lafont, A., Guzman, L.A., Whitlow, P.L., Goormastic, M., Cornhill, J.F., Chilsolm, G.M. (1995a) Restenosis after experimental angioplasty: intimal, medial and adventitial changes associated with constrictive remodelling. Circ. Res., 76:996-1002.
84. Lafont, A., Guerot, C., Lemarchand, P. (1995b) Which gene for which restenosis? Lancet, 346:1442-1443.
85. Lafont, A. and Faxon, D. (1998) Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials? Cardiovasc. Res., 39:50-59.
86. Laitinen, M., Pakkanen, T., Donetti, E., Baetta, R., Luoma, J., Lehtolainen, P., Viita, H., Agrawal, R., Miyanohara, A., Friedmann, T., Risau, W., Martin, J.F., Soma, M., Ylä-Herttuala, S. (1997) Gene transfer into the carotid artery using an adventitial collar: Comparison of the effectiveness of the plasmid-liposome comlexes, retroviruses, pseudotyped retroviruses and adenoviruses. Hum. Gene. Ther., 8:1645-1650.
87. Laitinen, M., Hartikainen, J., Hiltunen, M.O., Eranen, J., Kiviniemi, M., Narvanen, O., Makinen, K., Manninen, H., Syvanne, M., Martin, J.F., Laakso, M., Yla-Herttuala, S. (2000) Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum. Gene. Ther., 11:263-270.
88. Lamfers, M.L.M., Lardenoye, J.H.P., de Vries, M.R., Aalders, M.C., Englese, M.A., Grimbergen, J.M., van Hinsbergh, V.W.M., Quax, P.H.A. (2001) In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI. Gene. Ther., 8:534-541.
89. Larson, R.A., Naji, M., Lombardi, J.V., Naji, A., Koeberlein, B., Golden, M.A. (2000) Adenoviral-mediated uteroglobin gene transfer inhibits neointimal hyperplasia after balloon injury in the rat carotid artery. J. Vasc. Surg., 32:1111-1117.
90. Laukkanen, M.O., Kivela, A., Rissanen, T., Rutanen, J., Karkkainen, M.K., Leppanen, O., Brasen, J.H., Yla-Herttuala, S. (2002) Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta. Circulation. 106:1999-2003.
91. Lewis, P.F., Emerman, M. (1994) Passage through mitosis is required for oncoretroviruses but not for human immunodeficiency virus. J. Virol., 68:510-516.
92. Li, G., Chen, S-J., Oparil, S., Chen, Y-F., Thompson, J.A. (2000) Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation, 101:1362-1365.
93. Libby, P, Gantz, P. (1997) Restenosis revisted: new targets; new therapies. N. Engl. J. Med., 337:418-419.
94. Libby, P. (1998) Gene therapy for restenosis. Promises and perils. Circ. Res., 82:404-406.
95. Lijnen, H.R. (2001) Plasmin and matrix metalloproteinases in vascular remodeling. Thromb. Haemost., 86:324-333.
96. Lincoff, A.M., Topol, E.J., Ellis, S.G. (1994) Local drug delivery for the prevention of restenosis. Fact, fancy and future. Circulation, 90:2070-2084.
97. Lombardi, J.V., Naji, M., Larson, R.A., Ryan, S.V., Naji, A., Koeberlein, B., Golden, M.A. (2001) Adenoviral mediated uteroglobin gene transfer to the adventitia reduces arterial intimal hyperplasia. J. Surg. Res., 99:377-380.
98. Luo, H., Nishioka, T., Eigler, N.L., Forrester, J.S., Fishbein, M.C., Berglund, H., Siegel, R.J. (1996) Coronary artery restenosis after balloon angioplasty in humans is associated with circumferential coronary constriction. Arterioscler. Thromb. Vasc. Biol., 16:1393-1398.
99. Luo, Z., Sata, M., Nguyen, T., Kaplan, J.M., Akita, G.Y., Walsh, K. (1999) Adenovirus-mediated delivery of Fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals. Circulation, 99:1776-1779.
100. Lynch, C.M., Hara, P.S., Leonard, J.C., Williams, J.K., Dean, R.H., Geary, R.L. (1997) Adeno-associated virus vectors for vascular gene delivery. Circ. Res., 80:497-505.
101. Maeda, Y., Ikeda, U., Ogasawara, Y., Urabe, M., Takizawa, T., Saito, T., Colosi, P., Kurtzman, G., Shimada, K., Ozawa, K. (1997) Gene transfer into vascular cells using adeno-associated virus (AAV) vectors. Cardiovasc. Res., 35:514-521.
102. Mahato, R.I., Smith, L.C., Rolland, A. (1999) Pharmaceutical perspectives of nonviral gene therapy. Adv. Genet., 41:95-156.
103. Maillard, L., Van Belle, E., Smith, R.C., Le Roux, A., Denéfle, P., Steg, G., Barry, J.J., Branellec, D., Isner, J.M., Walsh, K. (1997) Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty. Cardiovasc. Res., 35:536-546.
104. Maillard, L., Van Belle, E., Tio, F.O., Rivard, A., Kearney, M., Branellec, D., Steg, P.G., Isner, J.M., Walsh, K. (2000) Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double injured atheromatous stented rabbit iliac arteries. Gene Ther., 7:1353-1361.
105. Mann, M.J., Morishita, R., Gibbons, G.H., von der Leyen, H.E., Dzau, V.J. (1997) DNA transfer into vascular smooth muscle cells using fusigenic Sendai virus (HJV)-liposomes. Mol. Cell. Biochem., 172:3-12.
106. Makinen, K., Manninen, H., Hedman, M., Matsi, P., Mussalo, H., Alhava, E., Yla-Herttuala, S. (2002) Increased Vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomised, placebo-controlled, double-blinded phase II study. Mol. Ther., 6:127-133.
107. Mano, T., Luo, Z., Malendowicz, S.L., Evans, T., Walsh, K. (1999) Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery. Circ. Res., 84:647-654.
108. Maresta, A., Balducelli, M., Cantini, L., Casari, A., Chioin, R., Fabbri, M., Fontanelli, A., Monici ,Preti, P.A., Repetto, S., De Servi, S., Varani, E. (1994) Trapidil, a PDGF antagonist, reduces restenosis after PTCA. Results of the randomised, double-blind STARC study. Circulation, 90:2710-2715.
109. Masaki, I., Yonemitsu, Y., Komori, K., Ueno, H., Nakashima, Y., Nakagawa, K., Fukumura, M., Kato, A., Hasan, M.K., Nagai, Y., Sugimachi, K., Hasegawa, M., Sueishi, K. (2001) Recombinant sendai virus-mediated gene transfer to vasculature: a new class of efficient gene transfer vector to the vascular system. FASEB J., 15:1294-1296.
110. McCaffrey, T.A., Du, B., Consigli, S., Szabo, P., Bray, P.J., Hartner, L., Weksler, B.B., Sanborn, T.A., Bergman, G., Bush, H.L. (1997) Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J. Clin. Invest., 100:2182-2188.
111. Mercurius, K.O. and Morla, A.O. (1998) Inhibition of vascular smooth muscle cell growth by inhibition of fibronectin matrix assembly. Circ. Res., 82:548-556.
112. Mintz, G.S., Popma, J.J., Pichard, A.D., Kent, K.M., Satler, L.F., Wong, C., Hong, M.K., Kovach, J.A., Leon, M.B. (1996) Arterial remodelling after Coronary angioplasty - a serial intravascular ultrasound study. Circulation, 94:35-43.
113. Miyatake, S-I., Yukawa, H., Toda, H., Matsuoka, N., Takahashi, R., Hashimoto, N. (1999) Inhibition of rat vascular smooth muscle cell proliferation in vitro and in vivo by recombinant replication-competent Herpes simplex virus. Stroke, 30:2431-2439.
114. Mori, E., Komori, K., Yamaoka, T., Tanii, M., Kataoka, C., Takeshita, A., Usui, M., Egashira, K., Sugimachi, K. (2002) Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodelling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation, 105:2905-2910.
115. Morishige, K., Shimokawa, H., Yamawaki, T., Miyata, K., Eto, Y., Kandabashi, T., Yogo, K., Higo, T., Egashira, K., Ueno, H., Takeshita, A. (2000) Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. J. Am. Coll. Cardiol., 35:1040-1047.
116. Mudra, H., Regar, E., Klauss, V., Werner, F., Henneke, K-H., Sbarouni, E., Theisen, K. (1997) Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. Circulation, 95:363-370.
117. Muller, D.W.M., Ellis, S.G., Topol, E.J. (1992) Experimental models of coronary artery restenosis. J. Am. Coll. Cardiol., 19:418-432.
118. Murakami, H., Yayama, K., Miao, R.Q., Wang, C., Chao, L., Chao, J. (1999) Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty. Hypertension, 34:164-170.
119. Nabel, E.G., Plautz, G., Boyce, F.M., Stanley, J.C., Nabel, G.J. (1989) Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science, 244:1342-1344.
120. Nakaoka, T., Gonda, K., Ogita, T., Otawara-Hamamoto, Y., Okabe, F., Kira, Y., Harii, K., Miyazono, K., Takuwa, Y., Fujita, T. (1997) Inhibition of rat vascular smooth muscle cell proliferation in vitro and in vivo by bone morphogenetic protein-2. J. Clin. Invest., 100:2824-2832.
121. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M., Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 272:263-267.
122. Nelken, N.A., Soifer, S.J., O'Keefe, J., Vu, T.K., Charo, I.F., Coughlin, S.R. (1992) Thrombin receptors expression in normal and atheroslcerotic human arteries. J. Clin. Inv., 90:1614-1621.
123. Newman, K.D., Dunn, P.F., Owens, J.W., Schulick, A.H., Virmani, R., Sukhova, G., Libby, P., Dichek, D.A. (1995) Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation and neointimal hyperplasia. J. Clin. Invest., 96:2955-2965.
124. Nikkari, S.T., Järveläinen, H.T., Wight, T.N., Ferguson, M., Clowes, A.W. (1994) Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am. J. Pathol., 44:1348-1356.
125. Nikol, S., Pelisek, J., Engelmann, M.G., Rolland, P.H., Armeanu, S. (2000) Prevention of restenosis using the gene for Cecropin complexed with DOCSPER liposomes under optimized conditions. Int. J. Angiol., 9:87-94.
126. Numaguchi, Y., Naruse, K., Harada, M., Osanai, H., Mokuno, S., Murase, K., Matsui, H., Toki, Y., Ito, T., Okumura, K., Hayakawa, T. (1999) Prostacyclin synthase gene transfer accelerates reendothelialization and inhibits neointimal formation in rat carotid arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol., 19:727-733.
127. O'Brien, E.R., Alpers, C.E., Stewart, D.K., Ferguson, M., Tran, N., Gordon, D., Benditt, E.P., Hinohara, T., Simpson, J.B., Schwartz, S.M. (1993) Proliferation in primary and restenotic coronary atherectomy tissue. Circ. Res., 73:223-231.
128. O'Brien, E.R., Urieli-Shoval, S., Garvin, M.R., Stewart, D.K., Hinohara, T., Simpson, J.B., Benditt, E.P., Schwartz, S.M. (2000) Replication in restenotic atherectomy tissue. Atherosclerosis, 152:117-126.
129. Ohno, T., Gordon, D., San, H., Pompili, V.J., Imperiale, M.J., Nabel, G.J., Nabel, E.G. (1994) Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science, 265:781-784.
130. Okazaki, H., Majesky, M.W., Harker, L.A., Schwartz, S.M. (1992) Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. Circ. Res., 71:1285-1293.
131. Ooboshi, H., Rios, C.D., Yi Chu, Y., Christenson, S.D., Faraci, F.M., Davidson, B.L., Heistad, D.D. (1997) Augmented Adenovirus-Mediated Gene Transfer to Atherosclerotic Vessels. Arterioscler. Thromb. Vasc. Biol., 17:1786-1792.
132. Panda, D., Kundu, G.C., Lee, B.I., Peri, A., Fohl, D., Chackalaparampii, I., Mukherjee, B.B., Li, X.D., Mukherjee, D.C., Seides, S., Rosenborg, J., Stark, K., Mukherjee, A.B. (1997) Potential roles of osteopontin and αVβ3 integrin in the development of coronary artery restenosis after angioplasty. Proc. Nat. Acad. Sci., 94:9308-9313.
133. Panetta, C.J., Miyauchi, K., Berry, D., Simari, R.D., Holmes, D.R., Schwartz, R.S., Caplice, N.M. (2002) A tissue-engineered stent for cell-based vascular gene transfer. Hum. Gene Ther., 13:433-441.
134. Patel, S., Shi, Y., Niculescu, R., Chung, E.H., Martin, J.L., Zalewski, A. (2000) Characteristics of coronary smooth muscle cells and adventitial fibroblasts. Circulation, 101:524-532.
135. Pauly, R.R., Passaniti, A., Bilato, C., Monticone, R., Cheng, L., Papadopoulos, N., Gluzband, Y.A., Smith, L., Weinstein, C., Lakatta, E.G., Crow, M.T. (1994) Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ. Res., 75:41-54.
136. Perlman, H., Luo, Z., Krasinski, K., Le Roux, A., Mahfoudi, A., Smith, R.C., Branellec, D., Walsh, K. (1999) Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle cell proliferation and induces apoptosis. Gene Ther., 6:758-763.
137. Pickering, J.G., Weir, L., Jekanowski, J., Kearney, M.A., Isner, J. (1993) Proliferation activity in peripheral and coronary atherosclerotic plaque in patients undergoing percutaneous revascularisation. J. Clin. Invest., 91:1460-1480.
138. Post, M.J., Borst, C., Kuntz, R.E. (1994) The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. Circulation, 89:2816-2821)
139. Pratt, R.E. and Dzau, V.J. (1996) Pharmacological strategies to prevent restenosis. Lessons learned from the blockade of the Renin-Angiotensin system. Circulation, 93:848-852.
140. Quarck, R., De Geest, B., Stengel, D., Mertens, A., Lox M., Theilmeier, G., Michiels, C., Raes, M., Bult, H., Collen, D., Van Veldhoven, P., Ninio, E., Holvoet, P. (2001) Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation, 103:2495-2500.
141. Quax, P.H.A., Lamfers, M.L.M., de Vries, M.R., Slomp, J., de Ruiter, M.C., Kockx, M.M., Verheijen, J.H., van Hinsbergh, V.W.M. (2001) Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels. Circulation, 103:562-569.
142. Rade, J.J., Schulick, A.H., Virmani, R., Dichek, D.A. (1996) Local adenoviral mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat. Med., 2:293-8.
143. Rasmussen, L.M., Wolf, Y.G., Ruoslahti, E. (1995) Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-β activity. Am. J. Pathol., 147:1041-1048.
144. Raugi, G.J., Mullen, J.S., Bark, D.H., Okada, T., Mayberg, M.R. (1990) Thrombospondin deposition in rat carotid artery injury. Am. J. Pathol., 137:179-185.
145. Rensing, B.J., Vos, J., Smits, P.C., Foley, D.P., van den Brand, M.J., van der Giessen, W.J., de Feijter, P.J., Serruys, P.W. (2001) Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur. Heart. J., 22:2125-30.
146. Ribault, S., Neuville, P., Méchine-Neuville, A., Augé, F., Parlakian, A., Gabbiani, G., Paulin, D., Calenda, V. (2001) Chimeric smooth muscle-specific enhancer/promoters. Valuable tools for adenovirus-mediated cardiovascular gene therapy. Circ. Res., 88:468-475.
147. Richter, M., Iwata, A., Nyhius, J., Nitta, Y., Miller, A.D., Halbert, C.L., Allen, M.D. (2000) Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol. Genomics, 2:117-127.
148. Riessen, R., Isner, J.M., Blessing, E., Loushin, C., Nikol, S., Wight, T.N. (1994) Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am. J. Pathol., 144:962-74.
149. Riessen, R., Isner, J.M., Pastore, C., Henley, C., Wright, T.N. (1996) Distribution of hyaluronan during extracellular matrix remodelling in human restenotic lesions and balloon injured rat carotid arteries. Circulation, 93:1141-1147.
150. Rivard, A. and Andres, V. (2000) Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular disease. Histol. Histopathol., 15:557-571.
151. Roks, A.J.M., Pinto, Y.M., Paul, M, Pries, F, Stula, M, Eshenhagen, T, Orzechowski, H-D, Gschwendt, S, Wilschut, J, van Gilst, WH. (1997) Vectors based on Semliki Forest virus for rapid and efficient gene transfer into non-endothelial cardiovascular cells: comparison to adenovirus. Cardiovasc. Res., 35:498-504.
152. Roks, A.J., Henning, R.H., Buikema, H., Pinto, Y.M., Kraak, M.J., Tio, R.A., de Zeeuw, D., Haisma, H.J., Wilschut, J., van Gilst, W.H. (2002) Recombinant Semliki Forest virus as a vector system for fast and selective in vivo gene delivery into balloon-injured rat aorta. Gene Ther., 9:95-101.
153. Rolling, F., Nong, Z., Pisvin, S., Collen, D. (1997) Adeno-associated virus-mediated gene transfer into rat carotid arteries. Gene Ther., 4:757-761.
154. Sabaté, M., Serruys, P.W., van der Giessen, W.J., Ligthart, J.M.R., Coen, V.L.M.A., Kay, P., Gijzel, A.L., Wardeh, A.J., den Boer, A., Levendag, P.C. (1999) Geometric vascular remodeling after balloon angioplasty and β-radiation therapy. Circulation, 100:1182-1188.
155. Sakoda, T., Kasahara, N., Hamamori, Y., Kedes, L. (1999) A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J. Mol. Cell. Cardiol., 31:2037-2047.
156. Santiago, F.S. and Khachigian, L.M. (2001) Nucleic acid based strategies as potential therapeutic tools: mechanistic considerations and implications to restenosis. J. Mol. Med., 79:695-706.
157. Sata, M., Perlman, H., Muruve, D.A., Silver, M., Ikebe, M., Libermann, T.A., Oettgen, P., Walsh, K. (1998) Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Nat. Acad. Sci., 95:1213-1217.
158. Scheinman, M., Ascher, E., Levi, G.S., Hingorani, A., Shirazian, D., Seth, P. (1999) p53 gene transfer to the injured rat carotid artery decreases neointimal formation. J. Vasc. Surg., 29:360-369.
159. Schiedner, G., Morral, N., Parks, R.J., Wu, Y., Koopmans, S.C., Langston, C., Graham, F.L., Beaudet, A.L., Kochanek, S. (1998) Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Genetics, 18:180-183.
160. Schulick, A.H., Newman, K.D., Virmani, R., Dichek, D.A. (1995) In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation, 91:2407-2414.
161. Schulick, A.H., Vassalli, G., Dunn, P.F., Dong, G., Rade, J.J., Zamarron, C., Dichek, D.A. (1997) Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. J. Clin. Invest., 99:209-219.
162. Schwartz, R.S., Holmes, D.R., Topol, E.J. (1992) The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J. Am. Coll. Cardiol., 20:1284-93.
163. Schwartz, S.M., Campell, G.R., Complex, J.H. (1986) Replication of SMC in vascular disease. Circ. Res., 58:427-444.
164. Schwartz, S.M., Holmes, D.R., Topol, E.J. (1992) The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J. Am. Coll. Cardiol., 20:1284-93.
165. Scott, N.A., Cipolla, G.D., Ross, C.E., Dunn, B., Martin, F.H., Simonet, L., Wilcox, J.N. (1996) Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation, 93:2178-2187.
166. Seabra-Gomes, R. (2001) Radioactive stents to reduce restenosis: time for an epitaph. Eur. Heart. J., 22:621-623.
167. Serruys, P.W., de Jaegene, P., Kiemoniej, F., Macaya, C., Heyndrickx, G., Emmanuelsson, H., Mario, J., Legrind, V., Mutene, P. et al. (1994) The Benestent Group. A comparison of balloon expandable stent implantation with PTCA in patients with coronary artery disease. N. Engl. J. Med., 331:489-495.
168. Serruys, P.W., Foley, D.P., Pieper, J.A., Kleijne, J.A., de Feyter, P.J. (2001) The TRAPIST study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ulrasound. Eur. Heart J., 22:1938-1947.
169. Shears, L.L., Kibbe, M.R., Murdock, A.D., Billiar, T.R., Lizonova, A., Kovesdi, I., Watkins, S.C., Tzeng, E. (1998) Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J. Am. Coll. Surg., 187:295-306.
170. Shi, Y., O'Brien, J.E., Fard, A., Mannion, J.D., Wang, D., Zalewski, A. (1996a) Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation, 94:1655-64.
171. Shi, Y., Pieniek, M., Fard, A., O'Brien, J., Mannion, J.D., Zalewski, A. (1996b) Adventitial remodelling after coronary arterial injury. Circulation, 93:340-348.
172. Shi, Y., O'Brien, JE., Ala-Kokko, L., Chung, W., Mannion, JD., Zalewski, A. (1997) Origin of extracellular matrix synthesis during coronary repair. Circulation, 95:997-1006.
173. Sibinga, N.E.S., Foster, L.C., Hsieh, C-M., Perrella, M.A., Lee, W-S., Endege, W.O., Sage, E.H., Lee, M-U., Haber, E. (1997) Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. Circ. Res., 80:532-541.
174. 1 gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects. Circ. Res., 88:103-109.
175. Sinnaeve, P., Chiche, J.D., Gillijns, H., Van Pelt, N., Wirthlin, D., Van der Werf, F., Collen, D., Bloch, K.D., Janssens, S. (2002) Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis. Circulation, 105:2911-2916.
176. Smith, R.C., Wills, K.N., Antelman, D., Perlman, H., Truong, L.N., Krasinski, K., Walsh, K. (1997a) Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation, 96:1899-1905.
177. CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev., 11:1674-1689.
178. Smith-Arica, J.R. and Bartlett, J.S. (2001) Gene therapy: recombinant adeno-associated virus vectors. Curr. Cardiol. Rep., 3:43-49.
179. Sousa, J.E., Costa, M.A., Abizaid, A.C., Rensing B.J., Abizaid, A.S., Tanajura, L.F., Kozuma, K., Van Langenhove, G., Sousa, A.G., Falotico, R., Jaeger, J., Popma, J.J., Serruys, P.W. (2001) Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation, 104:2007-2011.
180. Southgate, K.M., Fisher, M., Banning, A.P., Thurston, V.J., Baker, A.H., Fabunmi, R.P., Groves, P.H., Davies, M., Newby, A.C. (1996) Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ. Res., 79:1177-1187.
181. Steg, P.G., Tahlil, O., Aubailly, N., Caillaud, J-M., Dedieu, J-F., Berthelot, K., Le Roux, A., Feldman, L., Perricaudet, M., Denèfle, P., Branellec, D. (1997) Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. Circulation, 96:408-411.
182. Stephan, D., San, H., Yang, Z., Gordon, D., Goelz, S., Nabel, G.J., Nabel, E.G. (1997) Inhibition of vascular smooth muscle cell proliferation and intimal hyperlpasia by gene transfer of β -interferon. Mol. Med., 3:593-599.
183. Strauss, B.H., Chisholm, R.J., Keeley, F.W., Gotlieb, A.I., Logan, R.A., Armstrong, P.W. (1994) Extracellular matrix remodelling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res., 75:650-58.
184. Tamai, H., Katoh, O., Suzuki, S., Fujii, K., Aizawa, T., Takase, S-i., Kurogane, H., Nishikawa, H., Sone, T., Sakai, K., Suzuki, T. (1999) Impact of Tranilast on restenosis after coronary angioplasty: Tranilast Restenosis Following Angioplasty Trial (TREAT). Am. Heart J., 138:968-975.
185. Tardif, J.C., Côté, G., Lesperance, J., Bourassa, M., Lambert, J., Doucet, S., Bilodeau, L., Nattel, S., de Guise, P. (1997) Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N. Engl. J. Med., 337:365-372.
186. Teirstein, P.S. (2001a) Living the dream of no restenosis. Circulation, 104:1996-1998.
187. Teirstein P.S. and Kuntz R.E. (2001b) New frontiers in interventional cardiology. Intravascular radiation to prevent restenosis. Circulation, 104:2620-2626.
188. Todaka, T., Yokoyama, C., Yanamoto, H., Hashimoto, N., Nagata, I., Tsukahara, T., Hara, S., Hatae, T., Morishita, R., Aoki, M., Ogihara, T., Kaneda, Y., Tanabe, T. (1999) Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats. Stroke, 30:419-426.
189. Topol, E. J., Leya, F., Pinkerton, C.A., Whitlow, P. L., Hofling, B., Simonton, C.A., Masden, R.R., Serruys, P.W., Leon, M.B., Williams, D.O., et al. for the CAVEAT Study Group. (1993) A Comparison Of Directional Atherectomy With Coronary Angioplasty In Patients With Coronary Artery Disease. New. Engl. J. Med., 329:221-227.
190. Topouzis, S. and Majesky, M.W. (1996) Smooth muscle cell lineage diversity in chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor mediated transcriptional responses to transforming growth factor β. Dev. Biol., 178:430-445.
191. Tsui, L.V., Camrud, A., Mondesire, J., Carlson, P., Zayek, N., Camrud, L., Donahue, B., Bauer, S., Lin, A., Frey, D., Rivkin, M., Subramanian, A., Falotico, R., Gyuris, J., Schwartz, R., McArthur, J.G. (2001) p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion. Circ. Res., 89:323-328.
192. Tulis, D.A., Durante, W., Liu, X., Evans, A.J., Peyton, K.J., Schafer, A.I. (2001) Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation, 104:2710-2715.
193. Tyagi, S.C., Meyer, L., Kumar, S., Schmaltz, R.A., Reddy, H.K., Voelker, D.J. (1996) Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions. Can. J. Cardiol., 12:353-62.
194. Ueno, H., Yamamoto, H., Ito, S.I., Li, J-J., Takeshita, A. (1997a) Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. Arterioscler. Thromb. Vasc. Biol., 17:898-904.
195. Ueno, H., Haruno, A., Morisaki, N., Furuya, M., Kangawa, K., Takeshita, A., Saito, Y. (1997b) Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation., 96:2272-2279.
196. van Belle, E., Tio, F.O., Chen, D., Maillard, L., Chen, D., Kearney, M., Isner, J.M. (1997) Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J. Am. Coll. Cardiol., 29:1371-1379.
197. Varenne, O., Pislaru, S., Gillijns, H., Van Pelt, N., Gerard, R.D., Zoldhelyi, P., Van de Werf, F., Collen, D., Janssens, S.P. (1998) Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation, 98:919-926.
198. Varenne, O., Gerard, R.D., Sinnaeve, P., Gillijns, H., Collen, D., Janssens, S. (1999) Percutaneous adenoviral gene transfer into porcine coronary arteries: Is catheter-based gene delivery adapted to coronary circulation? Hum. Gene. Ther., 10:1105-1115.
199. Varenne, O., Sinnaeve P., Gillijns, H., Iung, B., Laurysens, V., Meurrens, K., Bout, B., Valerio, D., Collen, D., Janssens, S.P., Gerard, R.D. (2000) Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries. Hum. Gene. Ther., 11:1329-1339.
200. Vermylen J. (1995) Clinical trials of primary and secondary prevention of thrombosis and restenosis. Thromb Haemost, 74:377-381.
201. van der Leyen, H.E., Gibbons, G.H., Morishita, R., Lewis, N.P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J.P., Dzau V.J. (1995) Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthetase gene. Proc. Nat. Acad. Sci., 92:1137-1141.
202. Wallner, K., Sharifi, B.G., Shah, P.K., Noguchi, S., DeLeon, H., Wilcox, J.N. (2001) Adventitial remodeling after angioplasty is associated with expression of tenascin mRNA by adventitial myofibroblasts. J. Am. Coll. Cardiol., 37:655-661.
203. Wang, R., Xu, M., Marcel, R., Bouliane, G., Fisher, D.Z. (1999) Selective neointimal gene transfer in an avian model of vascular injury. Atherosclerosis. 146:71-82.
204. Watanabe, K., Sekiya, M., Ikeda, S., Miyagawa, M., Hashida, K. (1996) Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am. Heart. J., 132:23-29.
205. Weissberg, P.L., Clesham, G.J., Bennett, M.R. (1996) Is vascular smooth muscle cell proliferation beneficial? Lancet, 347:305-307.
206. Wu, C.H., Lin, C.S., Hung, J.S., Wu, C.J., Lo, P.H., Jin, G., Shyy, Y.J., Mao, S.J., Chien, S. (2001) Inhibition of neointimal formation in porcine coronary artery by a Ras mutant. J. Surg. Res., 99:100-106.
207. Xu F., Prescott M.F., Liu P.X., Chen Z.H., Liao G., Gordon, E.M., Hall, F.L. (2001) Long term inhibition of neointima formation in balloon-injured rat arteries by intraluminal instillation of a matrix-targeted retroviral vector bearing a cytocidal mutant cyclin G1 construct. Int. J. Mol. Med., 8:19-30.
208. Yang, Z-Y., Simon, R.D., Perkins, N.D., San, H., Gordons, D., Nabel, G.J., Nabel E.G. (1996) Role of p21 cyclin dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc. Natl. Acad. Sci., 93:7905-7910.
209. Ye, Y.W., Landau, C., Meidell, R.S., Willard, J.E., Moskowitz, A., Aziz, S., Carlise, E., Nelson, K., Eberhart, R.C. (1996) Improved bioresorbable microporous intravascular stents for gene therapy. ASAOI J. 1996; 42:M823-M827.
210. Yin, X., Yutani, C., Ikeda, Y., Enjyoji, K., Ishibashi-Ueda, H., Yasuda, S., Tsukamoto, Y., Nonogi, H., Kaneda, Y., Kato, H. (2002) Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries. Cardiovasc. Res., 56:454-463.
211. Yokoi, H., Daida, H,. Kuwabara, Y., Nishikawa, H., Takatsu, F., Tomihara, H., Nakata, Y., Kutsumi, Y., Ohshima, S., Nishiyama, S., Seki, A., Kato, K., Nishimura, S., Kanoh, T., Yamaguchi, H. (1997) Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: The Probucol angioplasty restenosis trial. J. Am. Coll. Cardiol., 30:855-862.
212. Yonemitsu, Y., Kaneda, Y., Tanaka, S., Nakashima, Y., Komori, K., Sugimachi, K., Sueishi, K. (1998) Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ. Res., 82:147-156.
213. Zempo, N., Koyama, N., Kenagy, R.D., Holly, J.L., Clowes, A.W. (1996) Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler. Thromb. Vasc. Biol., 16:28-33.
214. Zoldhelyi, P., McNatt, J., Xu, X. M., Loose-Mitchell, D., Meidell, R.S., Clubb, F. J., Buja, L.M., Willerson, J.T., Wu, K.K., (1996) Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Circulation, 93:10-17.
215. Zoldhelyi, P., Chen, Z.Q., Shelat, H.S., McNatt, J.M., Willerson, J.T. (2001) Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl. Acad. Sci., 98:4078-83.